Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antihypertensive therapy and renal function

A Mimran1

  • 1Department of Medicine and Hypertension, Centre Hospitalier Universitaire, Hôpital Lapeyronie, Montpellier, France.

Journal of Cardiovascular Pharmacology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Left ventricular function in hypertension without left ventricular hypertrophy: echographic study with modelisation of left ventricular-aortic coupling].

Annales de cardiologie et d'angeiologie·2014
Same author

Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).

Journal of human hypertension·2010
Same author

Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.

Clinical and vaccine immunology : CVI·2010
Same author

Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.

Diabetologia·2009
Same author

[Hypertension and the renin-angiotensin-aldosterone pathway].

La Revue de medecine interne·2007
Same author

[Renin-angiotensin system inhibition and cardiac and renal alteration induced by a high sodium diet in rat].

Archives des maladies du coeur et des vaisseaux·2006
Same journal

Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

Journal of cardiovascular pharmacology·2026
Same journal

A Comprehensive Review of PCSK9 Inhibitor Therapy.

Journal of cardiovascular pharmacology·2026
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
See all related articles

Predicting progressive renal failure in essential hypertension requires further study. Long-term research is needed to understand how blood pressure and drug therapies affect kidney function and albuminuria.

Area of Science:

  • Nephrology
  • Hypertension Research
  • Pharmacology

Background:

  • Untreated essential hypertension can cause renal abnormalities.
  • Predictors of progressive renal failure in hypertensive patients are not well understood.
  • Optimal blood pressure targets and renal-protective drug therapies remain unclear.

Purpose of the Study:

  • To identify predictors of progressive renal failure in essential hypertension.
  • To evaluate the long-term effects of antihypertensive therapies on renal function and hemodynamics.
  • To determine the ideal drug therapy for renal and cardiovascular protection in hypertension.

Main Methods:

  • Review of existing literature on hypertension and renal function.
  • Analysis of clinical trial data on antihypertensive agents.

Related Experiment Videos

  • Longitudinal studies monitoring renal function and albuminuria over extended periods.

    • Main Results:

    • Most antihypertensive monotherapies show no consistent effect on renal function or hemodynamics over several months.
    • Antihypertensive agents may vary in their impact on markers like albuminuria.
    • Data on very long-term therapy effects on glomerular filtration rate are limited.

    Conclusions:

    • Further long-term studies are essential to understand the evolution of renal function in hypertension.
    • Reliable indicators for assessing changes in glomerular filtration rate are needed.
    • Identifying optimal treatment strategies for preserving kidney function in hypertensive patients requires more research.